Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Stonepine Capital Management »

Xilio Therapeutics shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Xilio Therapeutics shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Stonepine Capital Management

Quarter filed	Position value	Share count	Share price at filing
2026-03-31	$540k	64k	8.41

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)

Verastem Com New (VSTM)

Adma Biologics (ADMA)

Tenax Therapeutics Com New (TENX)

Camp4 Therapeutics Corp (CAMP)

Nektar Therapeutics Com New (NKTR)

Terns Pharmaceuticals Call Option (TERN)

Zevra Therapeutics Com New (ZVRA)

Abeona Therapeutics Com New (ABEO)

Corbus Pharmaceuticals Hldgs Com New (CRBP)

Establishment Labs Holdings Ord Call Option (ESTA)

Kazia Therapeutics Sponsored Ads (KZIA)

An2 Therapeutics (ANTX)

Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors

Frazier Life Sciences Management

Sio Capital Management

Vanguard Capital Management

Caligan Partners

Stonepine Capital Management

Renaissance Technologies

AJU IB Investment

Geode Capital Management

Vanguard Fiduciary Trust

GSA Capital Partners

Velan Capital Investment Management

View all funds holding Xilio Therapeutics

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z